Project Grant HT94252310518
Award Date
7/1/23
Completion Date
6/30/26
Dollars Obligated
$658K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
New York, NY 10032, USA
Similar Awards
The Trustees of Columbia University in New York City will receive $567,000 from the Department of the Army Medical Command under a three-year Project Grant award to identify epigenetic vulnerabilities in peripheral T-cell lymphomas. The grant period runs from September 1, 2022 through August 31, 2025. The funding supports research conducted under the Military Medical Research and Development program (CFDA 12.420), which aims to transform military and public health through innovative biomedical...
The Trustees of Columbia University in the City of New York, doing business as Health Sciences Division, was awarded a $656,272 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports research aimed at optimizing PD-1 immunotherapy through increased T cell regeneration and reduced antigen load. This 2-year project will be conducted in New York, NY from September 1, 2023 to August 31, 2025. The Military Medical...
The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, received a $567,654 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This funding supports spatial profiling of early, osimertinib-resistant brain lesions in EGFR-mutant lung cancer models over the 2-year period from July 1, 2023 to June 30, 2025. Through this grant, Columbia University will conduct biomedical research...
The Trustees of Columbia University in New York City will receive $486,000 under a two-year Project Grant from the Department of the Army Medical Command's Military Medical Research and Development program. The grant will fund research into novel regulators of lineage plasticity in castration-resistant prostate cancer. Through this funding, Columbia University researchers will investigate medical solutions for prostate cancer that persists despite hormone therapy, with the goal of transforming...
The Defense Health Agency awarded a $658,000 Project Grant to The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "OVERCOMING IMMUNOTHERAPY RESISTANCE IN CCNE1-AMPLIFIED STOMACH CANCER", is intended to support research to improve treatment options for stomach cancer patients. The 3-year project will run from May 1, 2024 to April 30, 2027....
The Trustees of Columbia University in New York City will receive $539,460 under a three-year Project Grant award from the Department of the Army Medical Command to investigate B7-H3 (CD276) as a therapeutic target in lethal prostate cancers. The grant was awarded on May 15, 2021 with a completion date of May 14, 2024. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to...
This federal Project Grant award from the Department of the Army Medical Command, under the Military Medical Research and Development (CFDA 12.420) program, provides $1,316,000.00 to support research by The Trustees of Columbia University in the City of New York on advancing the therapeutic target WRN for microsatellite instability-high (MSI-H) cancers. The award has a performance period from August 1, 2025 to July 31, 2029. As a prominent academic research institution, Columbia University...
The Trustees of Columbia University in the City of New York received a three-year, $729,000 Project Grant award from the Department of the Army Medical Command. The grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care. Under this award, Columbia University will conduct research from March 2021 to February 2024 to decipher the mechanisms that drive breast...
This $650,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports advanced biomedical research conducted by The Trustees of Columbia University's Health Sciences Division. The award, effective April 15, 2025 through April 14, 2028, will fund research on the "Psychiatric Aspects of Post-Traumatic Epilepsy." As a prominent academic research institution, Columbia University leverages its...
The Trustees of Columbia University in New York City will receive $729,000 from the Department of the Army Medical Command under a three-year Project Grant award titled "Eliminating Minimal Residual Disease After Targeted Therapy in Breast Cancer." The grant is part of the Military Medical Research and Development program administered by the agency, with a focus on transforming health care for service members and the public through innovative biomedical research. Under the award,...